00163UAD8
Amag Pharmaceuticals Inc
Could not find a ticker for this position, may be a filing error
A biopharmaceutical company that grew out of nanoparticle science, AMAG Pharmaceuticals began in 1981 as Advanced Magnetics, Inc., making iron-oxide particles used to brighten MRI scans. It later shifted to therapeutics, selling Feraheme, an intravenous iron treatment for anemia, and Makena, a drug to lower the risk of preterm birth. The company took the AMAG name in 2007 and was folded into Covis Pharma in 2020.
CONVERTIBLEUnderlying: AMAGCUSIP: 00163UAD8HealthcareUS1 derivative reporter
3.25% Convertible Senior Notes due June 1, 2022
No tracked superinvestor held this security as stock in this period — only the derivative positions below reference it.
Derivative Reporters
Investor
Kind
13F reported value
Quantity
Change
